Biogen to cut 1,000 jobs as focus turns to Alzheimer's drug Leqembi launch
Biogen said it expects to eliminate roughly 1,000 positions to save money ahead of launching a new drug to treat Alzheimer's disease. Investors are pinning their hopes on Leqembi, as the U.S. biotech company hopes to use the new treatment as a springboard for a return to growth, amid fierce…
#biogen #leqembi #sma #eisai #mexico